Skip to main content
. 2024 Nov 16;14:28267. doi: 10.1038/s41598-024-79556-z

Table 4.

Outcomes.

Overall CA-CNSI HAVM p-Value
NCCU-LOS (days, median [IQR]) 25 [16 – 30] 22 [6 – 30] 25.5 [19.25 – 30] 0.369
H-LOS (days, median [IQR]) 29 [23– 60.5] 26 [23 – 48] 40 [27.25 – 61.75] 0.331
mRS at discharge 0.525
No symptoms (n (%)) 0 (0.0) 0 (0.0) 0 (0.0)
No significant disability (n (%)) 1 (3.7) 1 (7.7) 0 (0.0)
Slight disability (n (%)) 4 (14.8) 3 (23.1) 1 (7.1)
Moderate disability (n (%)) 4 (14.8) 2 (15.4) 2 (14.3)
Moderate-severe disability (n (%)) 4 (14.8) 1 (7.7) 3 (21.4)
Severe disability (n (%)) 9 (33.3) 3 (23.1) 6 (42.9)
Death (n (%)) 5 (18.5) 3 (23.1) 2 (14.3)
mRS at 6 months 0.729
No symptoms (n (%)) 3 (16.7) 2 (20.0) 1 (12.5)
No significant disability (n (%)) 1 (5.6) 1 (10.0) 0 (0.0)
Slight disability (n (%)) 4 (22.2) 3 (30.0) 1 (12.5)
Moderate disability (n (%)) 4 (22.2) 2 (20.0) 2 (25.0)
Moderate-severe disability (n (%)) 3 (16.7) 1 (10.0) 2 (25.0)
Severe disability (n (%)) 3 (16.7) 1 (10.0) 2 (25.0)
Death (n (%)) 0 (0.0) 0 (0.00) 0 (0.0)
mRS at 12 months 0.657
No symptoms (n (%)) 3 (18.8) 2 (22.2) 1 (14.3)
No significant disability (n (%)) 2 (12.5) 2 (22.2) 0 (0.0)
Slight disability (n (%)) 2 (12.5) 1 (11.1) 1 (14.3)
Moderate disability (n (%)) 2 (12.5) 1 (11.1) 1 (14.3)
Moderate-severe disability (n (%)) 4 (25.0) 1 (11.1) 3 (42.9)
Severe disability (n (%)) 1 (6.2) 1 (11.1) 0 (0.0)
Death (n (%)) 2 (12.5) 1 (11.1) 1 (14.3)
mRS at 24 months 0.119
No symptoms (n (%)) 2 (20.0) 2 (40.0) 0 (0.0)
No significant disability (n (%)) 2 (20.0) 2 (40.0) 0 (0.0)
Slight disability (n (%)) 0 (0.0) 0 (0.0) 0 (0.0)
Moderate disability (n (%)) 3 (30.0) 1 (20.0) 2 (40.0)
Moderate-severe disability (n (%)) 2 (20.0) 0 (0.0) 2 (40.0)
Severe disability (n (%)) 0 (0.0) 0 (0.0) 0 (0.0)
Death (n (%)) 1 (10.0) 0 (0.0) 1 (20.0)

CA-CNSI, community-acquired central nervous system infection; HAVM (healthcare-associated ventriculitis and meningitis); H-LOS (hospital length of stay); NCCU-LOS (neurocritical care unit length of stay); mRS (modified Rankin Scale). Comparisons among patients with CA-CNSI and those with HAVM were performed.